NCT00004646View on ClinicalTrials.gov

Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 1995

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

prednisone

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

University of Rochester

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004646 - Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter